Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Protheroe

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Annals of Surgical Oncology|September 19, 2013
Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtypeLee J McGhan, Ann E McCullough, Cheryl A Protheroe, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red"James J Lee, Elizabeth A Jacobsen, Sergei I Ochkur, et al.
Journal of Immunological Methods|July 4, 2012
A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sourcesSergei I Ochkur, John Dongil Kim, Cheryl A Protheroe, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2014
Eosinophil-dependent skin innervation and itching following contact toxicant exposure in miceJames J Lee, Cheryl A Protheroe, Huijun Luo, et al.
The Lancet. Oncology|August 28, 2020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyLennard Y W Lee, Jean-Baptiste Cazier, Thomas Starkey, et al.
Lancet (London, England)|June 1, 2020
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyLennard Yw Lee, Jean-Baptiste Cazier, Vasileios Angelis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocolM R Sydes, M R Spears, M D Mason, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003N W Clarke, A Ali, F C Ingleby, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Annals of Surgical Oncology|September 19, 2013
Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtypeLee J McGhan, Ann E McCullough, Cheryl A Protheroe, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red"James J Lee, Elizabeth A Jacobsen, Sergei I Ochkur, et al.
Journal of Immunological Methods|July 4, 2012
A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sourcesSergei I Ochkur, John Dongil Kim, Cheryl A Protheroe, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2014
Eosinophil-dependent skin innervation and itching following contact toxicant exposure in miceJames J Lee, Cheryl A Protheroe, Huijun Luo, et al.
The Lancet. Oncology|August 28, 2020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyLennard Y W Lee, Jean-Baptiste Cazier, Thomas Starkey, et al.
Lancet (London, England)|June 1, 2020
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort studyLennard Yw Lee, Jean-Baptiste Cazier, Vasileios Angelis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocolM R Sydes, M R Spears, M D Mason, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003N W Clarke, A Ali, F C Ingleby, et al.
Pageof 4